These data reveal variable levels of hormone receptors and cytokine expression which may explain the inconsistent response of breast cancers to hormone therapies and suggest a mechanism by which some patients experience recurrent disease whereas others achieve long term remission. This evidence concerns the gene NR4A1 and breast carcinoma.